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The capsid of hepatitis B virus (HBV), which consists of hepatitis B core antigen 
(HBcAg) has become one of the most frequently studied viral-like-particle (VLP) for 
the display of foreign epitopes. Many studies have been carried out to purify this 
capsid. However, the conventional method of purification requires multiple steps of 
operation, which could lead to excessive product loss and high production costs. 
Therefore, it is of importance to develop a fast and cost effective protein recovery 
method such as expanded bed adsorption chromatography (EBAC) to ensure a better 
and efficient recovery of protein, especially in large scale downstream process.  
 
In this study, thermal treatment of the Escherichia coli cell feedstock at 60oC for 30 
min prior to solid removal in the conventional method has resulted in 1.4 times and 
18% higher in purity and recovery yield respectively compared to non-heat-treated 
feedstock. In direct capture of HBcAg from unclarified feedstock using the 
STREAMLINE DEAE (weak anion-exchangers) in batch adsorption, heat treatment 
at 60oC for 45 min has increased the recovery yield and purity by 2.3 and 3.8 times 
 ii
respectively compared with non-heat-treated feedstock. When these conditions were 
applied in large scale purification of HBcAg via EBAC, the yield and purity have 
increased by 1.2 and 1.8 folds respectively, compared with that purified from non-
heat-treated feedstock. Heating the crude feedstock has resulted in denaturation and 
precipitation of contaminants in the feedstock, hence reducing non-specific 
interactions between the cell debris and anion-exchanger. The present study has also 
demonstrated that purification of HBcAg from heat-treated unclarified feedstock was 
most efficient when EBAC operation using FastlineTM 20 contactor was operated at 
constant velocity (127.9 cm/h) in feedstock containing 5% of biomass. Although the 
current study showed that heat-treatment of unclarified feedstock could increase the 
purity of HBcAg and reduced non-specific binding of contaminant onto Streamline 
DEAE, the purity obtained was lower compared with that purified using conventional 
methods. Therefore, development of an affinity adsorbent using M13 phage bearing a 
disulfide constrained heptapeptide at the gpIII protein coat with the sequence, C-
WSFFSNI-C as the ligand has been carried out in this study. M13 phage immobilised 
onto Streamline Base Matrix via epoxy activation was used in direct capture of 
HBcAg from unclarified feedstock via two different modes of EBAC operations; 
typical single pass operation and modified EBAC operation with recirculation of 
feedstock. 
 
 Higher yield of HBcAg was obtained using modified EBAC operation due to 
increase in protein residence time in the column, however, the purity was reduced by 
15% compared with typical EBAC operation, which could be due to diffusion of 
contaminants into the internal volume of the macroporous adsorbents. Although the 
purity of HBcAg recovered using M13 phage ligand adsorbents was higher (70-80%) 
 iii
but the yield was lower compared with that purified using anion-exchanger. 
Therefore, this study showed that peptide displayed on M13 phage can be employed 
as an affinity ligand in direct capture of HBcAg from unclarified feedstock using 
EBAC. When analysed with ELISA, the antigenicity of HBcAg purified using both 
adsorbents in EBAC was still preserved.  
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Kapsid virus hepatitis B (HBV) yang terdiri daripada antigen teras (HBcAg) telah 
menjadi salah satu daripada partikel bak virus (VLP) yang kerap digunakan untuk 
mempamerkan epitop asing. Pelbagai kajian telah dijalankan untuk penulenan 
HBcAg, akan tetapi, kaedah konvensional memerlukan beberapa langkah penjernihan 
yang boleh mengakibatkan kehilangan protein, kapital dan kos buruh yang tinggi 
serta masa pemprosesan yang panjang. Oleh itu, kaedah penulenan yang berkesan, 
murah dan pantas seperti penjerapan lapisan terkembang kromatografi (EBAC) harus 
digunakan, terutamanya dalam pelaksanaan skala besar.  
 
Dalam kajian ini, rawatan haba ke atas suapan Escherichia coli dalam penulenan 
konvensional pada suhu 60oC selama 30 min telah menyebabkan peningkatan 
ketulenan sebanyak 1.4 kali dan 18% dalam hasilan terakhir jika dibandingkan 
dengan suapan tanpa rawatan haba. Di dalam penulenan langsung HBcAg dari 
suapan tanpa penjernihan menggunakan Streamline DEAE (penjerap penukaran 
 v
anion lemah) dalam penjerapan kelompok, rawatan haba pada suhu 60oC selama 45 
min telah meningkatkan hasilan terakhir sebanyak 2.3 kali dan 3.8 kali dalam 
ketulenan HBcAg berbanding dengan suapan tanpa rawatan haba.  Apabila ciri-ciri 
rawatan haba ini digunakan dalam penulenan HBcAg pada skala besar menggunakan 
EBAC, peningkatan sebanyak 1.2 dan 1.8 kali masing-masing dalam hasilan terakhir 
dan ketulenan HBcAg berbanding dengan suapan tanpa rawatan. Rawatan haba ke 
atas suapan telah menyebabkan penyahaslian dan pemendakan bendasing lalu 
mengurangkan interaksi di antara bendasing dengan penjerap penukaran anion. 
Kajian ini juga telah menunjukkan bahawa penulenan HBcAg daripada suapan tanpa 
penjernihan yang telah dirawat adalah lebih berkesan jika operasi EBAC 
menggunakan turus FastlineTM 20 dilaksanakan pada halaju malar (127.9 cm/j) 
dengan suapan tanpa penjernihan yang mengandungi 5% berat basah biojisim 
(berat/isipadu). Walaupun ketulenan HBcAg diperolehi daripada suapan yang telah 
melalui rawatan haba telah meningkat jika dibandingkan dengan tanpa rawatan, 
ketulenannya masih tidak setaraf dengan apa yang diperolehi dengan kaedah 
konvensional. Oleh itu, penjerapan affiniti menggunakan faj M13 yang membawa 
peptida C-WSFFSNI-C telah digunakan dalam pemulihan secara langsung HBcAg 
melalui EBAC. Faj M13 telah dipegunkan pada Streamline matrik basal melalui 
pengaktifan epoksi dan telah digunakan dalam dua operasi EBAC yang berlainan 
iaitu operasi biasa EBAC dan operasi EBAC yang telah diubahsuaikan dengan 
pengitaran semula suapan secara berterusan melalui lapisan terkembang dalam turus.  
 
Walaupun hasilan terakhir HBcAg melalui penulenan operasi EBAC yang telah 
diubahsuai adalah lebih tinggi berbanding dengan operasi biasa, tahap ketulenan 
yang diperolehi telah menurun sebanyak 15% akibat daripada resapan bendasing ke 
 vi
 vii
isipadu dalaman penjerap bermakroliang. Ketulenan HBcAg yang diperolehi melalui 
penjerapan affiniti ini adalah lebih tinggi jika berbanding dengan penjerapan 
penukaran anion (melebihi 80% ketulenan) walaupun hasilan terakhirnya adalah 
lebih rendah. Dengan itu, kajian ini telah membuktikan bahawa pembawa peptida faj 
M13 boleh digunakan sebagai penjerap affiniti dalam pemulihan secara langsung 
HBcAg melalui EBAC. Apabila HBcAg yang diperolehi melalui kedua-dua kaedah 
penjerapan dianalisis dengan menggunakan kaedah ELISA, tahap keantigenannya 
masih dikekalkan. 
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CHAPTER 1 
 
INTRODUCTION 
 
Capsid of the hepatitis B virus (HBV), which is composed of multiple subunits of 
core antigens (HBcAg) has become one of the most studied viral-like-particle (VLP) 
that possess similar morphology and self-assemble ability to the native capsids 
without involvement of the viral genome (Pumpens and Grens, 2001). HBcAg is a 
strong immunogen (Milich et al., 1997; Milich and McLachlan, 1986), and its 
capability in generating both humoral and cell-mediated immunity has made hepatitis 
B virus (HBV) core particle an excellent tool in delivering antigens for vaccination 
purpose (Nassal et al., 2008; Chen et al., 2004). This has also benefited in 
development of various immunoassays that are promising to use as diagnostic 
reagents (Li et al., 2007; Touze et al., 1999). Therefore, the quality of HBcAg should 
not be compromised as presence of impurities could lead to various problems such as 
inaccuracies in detection of specific antibodies in diagnostic kit (Li et al., 2007). 
Therefore, due to the wide spread application of HBcAg, it is essential to produce 
this protein at low cost in both upstream and downstream processes 
(Mechtcheriakova et al., 2006). However, apart from being too tedious to perform as 
it requires rounds of clarification steps, the available current method of HBcAg 
purification such as size-exclusion chromatography (Tang et al., 2007; Broos et al., 
2007) and sucrose gradient ultracentrifugation (Huang et al., 2006; Tan et al., 2003), 
also involves higher production cost, longer processing time and low in product yield 
(Rolland et al., 2001).  
 
Therefore, alternative method such as expanded bed adsorption chromatography 
(EBAC) can be sought to improve the downstream process of HBcAg. EBAC has 
long been used in direct recovery of biomolecules from various sources such as E. 
coli and yeast cells homogenate (Chow et al., 2007; Tan et al., 2005; Chase and 
Draeger, 1992) as well as more complex feedstocks such as plant extracts (Valdès et 
al., 2003) and chicken egg white (Chang and Chang, 2006) without the need of pre-
clarification steps. Unlike the conventional packed-bed chromatography that requires 
particulate-free feed stream, this method of purification forms a stable expanded bed 
that allows unhindered passage for cell or cells debris to flow through the column 
without the risk of clogging up the bed (Chase, 1994). Furthermore, EBAC combines 
three important steps in purification; clarification, capture and concentration steps 
into one single operation, hence, resulted in shorter processing time (Anspach et al., 
1999; Chase and Draeger, 1992). 
 
At present, the commonly-used EBAC matrices are ion-exchangers (Clemmitt and 
Chase, 2002) and metal-chelating (Tan et al., 2005) adsorbents. However, EBAC 
operation using ion-exchangers is greatly influenced by electrostatic interactions 
between cell or cell debris in the feedstock and the adsorbent (Lin et al., 2003) as 
well as the viscosity and ionic strength of the applied feedstock (Chang and Chase, 
1996a; Anspach et al., 1999). Therefore, affinity ligands are preferred as they are less 
likely to be affected by the aforementioned factors (Chase and Draeger, 1992). 
Unlike packed bed chromatography resin, affinity chromatographies in EBAC are 
usually carried out using commercially-available affinity ligands such as metal ions 
(Tan et al., 2005) and dye-ligand (Reichert et al.,  2001). In view of these, many new 
solid phases, which can be chemically-linked with various synthetic and biological 
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